Carbacyclin induces carnitine palmitoyltransferase-1 in cardiornyocytes via peroxisome proliferator-activated receptor (PPAR) δ independent of the IP receptor signaling pathway

被引:5
作者
Kuroda, Tadashi [1 ]
Hirota, Hisao [1 ]
Fujio, Yasushi [1 ]
Suglyama, Shoko [1 ]
Masaki, Mitsuru [1 ]
Hiramoto, Yoshimune [1 ]
Shioyama, Wataru [1 ]
Okamoto, Kitaro [1 ]
Horl, Masatsugu [1 ]
Yamauchi-Takihara, Keiko [1 ]
机构
[1] Osaka Univ, Grad Sch, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan
关键词
prostacyclin; PPAR; PPRE; CPT-1; cardiac energy metabolism;
D O I
10.1016/j.yjmcc.2007.04.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prostacyclin (PG12) and its analogues exert cardioprotective effects via the rhodopsin type membrane PG12 receptor, IP. Peroxisome proliferator-activated receptor (PPAR) delta is a nuclear receptor abundantly expressed in cardionnyocytes and plays a pivotal role in maintaining constitutive mitochondrial fatty acid l beta-oxidation (FAO). Recently, a novel signaling pathway of PG12 via PPAR delta has been demonstrated in non-cardiac tissues. We therefore examined whether carbacyclin (cPG12), a PG12 analogue, up-regulates transcriptional expression of carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting enzyme in mitochondrial FAO, via PPAR delta in cardiomyocytes. Intraperitoneal injection of cPG12 increased CPT-1 mRNA expression in murine hearts. Transcriptional activity was evaluated by PPAR responsive element (PPRE)-luciferase reporter gene assay in cultured neonatal rat cardiomyocytes. CPT-I mRNA expression and PPRE promoter activity were significantly increased by cPG12 in a concentration-dependent manner, where PPRE has been mapped to the promoter region of the CPT-1 gene. Moreover, the elevation of CPT-1 mRNA expression and PPRE promoter activity by cPG12 was not abolished by H-89, a potent protein kinase A inhibitor, but was significantly inhibited in cardiomyocytes over-expressing a dominant-negative type of PPAR delta. Furthermore, electrophoretic mobility shift assays demonstrated that binding of PPAR delta to PPRE in the CPT-1 gene promoter is enhanced in response to cPG12 stimulation. In addition, down-regulation of CPT-] mRNA expression in cardiomyocytes subjected to hypoxia was attenuated by cPG12. These results indicate that cPG12 induces CPT-1 mRNA expression through PPAR delta, independent of the IP receptor signaling pathway, suggesting a possibility that cPG12 modulates cardiac energy metabolism by activating FAO via PPAR delta. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:54 / 62
页数:9
相关论文
共 29 条
[1]   Evidence for a novel regulatory pathway activated by (carba)prostacyclin in preadipose and adipose cells [J].
Aubert, J ;
Ailhaud, G ;
Negrel, R .
FEBS LETTERS, 1996, 397 (01) :117-121
[2]   Prostanoid therapy for pulmonary arterial hypertension [J].
Badesch, DB ;
McLaughlin, VV ;
Delcroix, M ;
Vizza, CD ;
Olschewski, H ;
Sitbon, O ;
Barst, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :56S-61S
[3]   The role of IP prostanoid receptors in inflammatory pain [J].
Bley, KR ;
Hunter, JC ;
Eglen, RM ;
Smith, JAM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (04) :141-147
[4]   ARTERIAL-WALLS GENERATE FROM PROSTAGLANDIN ENDOPEROXIDES A SUBSTANCE (PROSTAGLANDIN-X) WHICH RELAXES STRIPS OF MESENTERIC AND CELIAC ARTERIES AND INHIBITS PLATELET-AGGREGATION [J].
BUNTING, S ;
GRYGLEWSKI, R ;
MONCADA, S ;
VANE, JR .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1976, 12 (06) :897-913
[5]   Peroxisome proliferator-activated receptor δ activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes [J].
Cheng, LH ;
Ding, GL ;
Qin, QH ;
Xiao, Y ;
Woods, D ;
Chen, YQE ;
Yang, QL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 313 (02) :277-286
[6]   Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy [J].
Cheng, LH ;
Ding, GL ;
Qin, QH ;
Huang, Y ;
Lewis, W ;
He, N ;
Evans, RM ;
Schneider, MD ;
Brako, FA ;
Xiao, Y ;
Chen, YQE ;
Yang, QL .
NATURE MEDICINE, 2004, 10 (11) :1245-1250
[7]   PROSTACYCLIN IS MAJOR PROSTAGLANDIN RELEASED FROM ISOLATED PERFUSED RABBIT AND RAT-HEART [J].
DEDECKERE, EAM ;
NUGTEREN, DH ;
HOOR, FT .
NATURE, 1977, 268 (5616) :160-163
[8]   Peroxisome proliferator-activated receptor δ as a molecular target to regulate lung cancer cell growth [J].
Fukumoto, K ;
Yano, Y ;
Virgona, N ;
Hagiwara, H ;
Sato, H ;
Senba, H ;
Suzuki, K ;
Asano, R ;
Yamada, K ;
Yano, T .
FEBS LETTERS, 2005, 579 (17) :3829-3836
[9]   Pulmonary prostacyclin, synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension [J].
Geraci, MW ;
Gao, BF ;
Shepherd, DC ;
Moore, MD ;
Westcott, JY ;
Fagan, KA ;
Alger, LA ;
Tuder, RM ;
Voelkel, NF .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) :1509-1515
[10]   Peroxisome proliferator-activated receptor (PPAR) α and PPARβ/δ, but not PPARγ, modulate the expression of genes involved in cardiac lipid metabolism [J].
Gilde, AJ ;
van der Lee, KAJM ;
Willemsen, PHM ;
Chinetti, G ;
van der Leij, FR ;
van der Vusse, GJ ;
Staels, B ;
van Bilsen, M .
CIRCULATION RESEARCH, 2003, 92 (05) :518-524